Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00303238 · ClinicalTrials.gov registry record · NA
Study to Evaluate the Effect of Botanical Dietary Supplements on Inflammation in Healthy People
A NA study, sponsored by Access Business Group.
- Completed
- Registry status
- NA
- Development phase
- 200
- Enrollment target
NCT00303238: Completed NA study, sponsored by Access Business Group.
NCT00303238 is a NA study that has completed, run by Access Business Group. The registered enrollment target is 200 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00303238, a NA study, has completed, sponsored by Access Business Group.
- COMPLETED
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
Study Summary
The purpose of the study is to evaluate the effect of botanical dietary supplements on inflammation in healthy people with different genetic responses to inflammation.
Interventions
- DRUG Rose hips extract + blueberry/blackberry extract + resveravine
- DRUG Rose hips extract + blueberry/blackberry extract + Aframomum melegueta extract
- DRUG Rose hips extract + resveravine + Aframomum melegueta extract
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2004-10 |
| Est. Completion | 2005-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00303238
The ClinicalTrials.gov registry entry for NCT00303238 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Access Business Group, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Rose hips extract + blueberry/blackberry extract + resveravine is the first listed.
NCT00303238 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00303238 about?
NCT00303238 is a clinical study titled "Study to Evaluate the Effect of Botanical Dietary Supplements on Inflammation in Healthy People". The purpose of the study is to evaluate the effect of botanical dietary supplements on inflammation in healthy people with different genetic responses to inflammation.
What is the current status of trial NCT00303238?
This trial is currently completed. It is a NA study. The enrollment target is 200 participants. The study started on 2004-10. Estimated completion is 2005-12.
What interventions are being tested in trial NCT00303238?
The interventions under investigation include: Rose hips extract + blueberry/blackberry extract + resveravine (DRUG), Rose hips extract + blueberry/blackberry extract + Aframomum melegueta extract (DRUG), Rose hips extract + resveravine + Aframomum melegueta extract (DRUG).
Who is sponsoring clinical trial NCT00303238?
This trial is sponsored by Access Business Group, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.